BACKGROUND: Individual factors in multiple sclerosis (MS) patients may modify the reliability of health-related quality of life (HRQOL) assessment. Knowledge of these effects may enable physicians to identify patients at risk for poor perceived health. OBJECTIVE: To investigate what individual factors may interact with MS symptoms and their severity to modify the reliability of HRQOL assessment; to explore the predictive values of the significant variables identified. METHODS: HRQOL was assessed in 57 patients by the 36-Item Short Form Health Survey (SF-36). The Physical Component Summary and Mental Component Summary were dichotomized and applied as dependent variables for logistic regression analysis. The Functional Independence Measu...
Traditional outcome measures for patients with multiple sclerosis (MS), whether in clinical trials o...
Objective: To explore the association between combined lifestyle risk factors with quality of life i...
Traditional outcome measures for patients with multiple sclerosis (MS), whether in clinical trials o...
BACKGROUND: Individual factors in multiple sclerosis (MS) patients may modify the reliability of he...
Multiple sclerosis (MS) is a common demyelinating chronic illness that primarily affects young adult...
Multiple sclerosis (MS) is a neurodegenerative and autoimmune disease, which can significantly affec...
International audienceINTRODUCTION: Knowledge of which factors are determinant of quality of life (Q...
Background: Quantifying the clinical impact of multiple sclerosis (MS) is one of the most important ...
BACKGROUND: Health-related quality of life (QOL) is a key outcome for people with multiple sclerosis...
Background: Risk factors for chronic disease include smoking, hazardous alcohol consumption, physica...
BACKGROUND Multiple Sclerosis (MS), a chronic disease of the central nervous system (CNS), affect...
BACKGROUND: People with MS are a heterogeneous population with varying difficulties and needs that a...
Multiple sclerosis (MS) is one of the most disabling chronic neurological diseases. Individual perce...
BACKGROUND AND OBJECTIVES: A few studies have found that low scores on self-rated health and qualit...
Objective: To determine the value of health-related quality of life (HRQoL) to predict change in dis...
Traditional outcome measures for patients with multiple sclerosis (MS), whether in clinical trials o...
Objective: To explore the association between combined lifestyle risk factors with quality of life i...
Traditional outcome measures for patients with multiple sclerosis (MS), whether in clinical trials o...
BACKGROUND: Individual factors in multiple sclerosis (MS) patients may modify the reliability of he...
Multiple sclerosis (MS) is a common demyelinating chronic illness that primarily affects young adult...
Multiple sclerosis (MS) is a neurodegenerative and autoimmune disease, which can significantly affec...
International audienceINTRODUCTION: Knowledge of which factors are determinant of quality of life (Q...
Background: Quantifying the clinical impact of multiple sclerosis (MS) is one of the most important ...
BACKGROUND: Health-related quality of life (QOL) is a key outcome for people with multiple sclerosis...
Background: Risk factors for chronic disease include smoking, hazardous alcohol consumption, physica...
BACKGROUND Multiple Sclerosis (MS), a chronic disease of the central nervous system (CNS), affect...
BACKGROUND: People with MS are a heterogeneous population with varying difficulties and needs that a...
Multiple sclerosis (MS) is one of the most disabling chronic neurological diseases. Individual perce...
BACKGROUND AND OBJECTIVES: A few studies have found that low scores on self-rated health and qualit...
Objective: To determine the value of health-related quality of life (HRQoL) to predict change in dis...
Traditional outcome measures for patients with multiple sclerosis (MS), whether in clinical trials o...
Objective: To explore the association between combined lifestyle risk factors with quality of life i...
Traditional outcome measures for patients with multiple sclerosis (MS), whether in clinical trials o...